Notice from the General Office of the Ministry of Agriculture and Rural Affairs on the 2026 First Batch of Veterinary Drug Quality Supervision and Sampling Results

(Source: China Animal Husbandry)

Source: China Animal Husbandry

Agricultural and Rural (Agriculture and Animal Husbandry), Veterinary Bureau (Department, Commission) of each province, autonomous region, and municipality directly under the central government, Xinjiang Production and Construction Corps Agriculture and Rural Affairs Bureau:

To strengthen the supervision of veterinary drug quality, according to the “2025 Veterinary Drug Quality Supervision and Sampling Plan,” our department organized random inspections of veterinary drug production, operation, and usage units. At the same time, we conducted follow-up inspections on veterinary drug products from enterprises identified as having potential risks during routine supervision. The following is a notification of the relevant situation of the fourth quarter 2025 supervision and sampling.

1. Overall Situation

One batch of unqualified veterinary biological products at the department level (see Attachment 1); 21 batches of unqualified veterinary drug products in the non-biological category at the provincial level (see Attachment 2); 3 batches of non-biological veterinary drug products at the department level follow-up inspection (see Attachment 3); 5 batches of counterfeit veterinary drugs found; 5 batches of veterinary drug products that do not meet the traceability QR code supervision requirements (see Attachment 4).

You can check the relevant information of veterinary drug quality supervision and sampling results through the “National Veterinary Drug Product Basic Data Query System” on the “China Veterinary Drug Information Network.”

2. Unqualified Product Situation

(1) Provincial supervision and sampling unqualified situation for non-biological veterinary drug products

1. Overall situation: Among the 21 unqualified products, chemical drugs, antibiotics, and traditional Chinese medicine products account for 10, 8, and 3 batches respectively. Enrofloxacin injection from Shandong Jinyang Biopharmaceutical Co., Ltd. was found to contain illegal additive ketoprofen.

2. Unqualified items: Of the 21 unqualified products, 15 batches failed in 1 item, 5 batches failed in 2 items, and 1 batch failed in 3 items.

(2) Department-level follow-up inspection unqualified situation for non-biological veterinary drug products

1. Overall situation: Among the 3 unqualified products, each is from chemical drugs, antibiotics, and traditional Chinese medicine categories, with 1 batch each.

2. Unqualified items: All 3 unqualified products failed in 1 item each.

(3) Discovery of counterfeit veterinary drugs and veterinary drug products not meeting traceability QR code supervision requirements

In provincial supervision and sampling, 5 batches of counterfeit veterinary drugs were found, and 4 batches of products not meeting traceability QR code supervision requirements. During department-level risk monitoring, 1 batch of products not meeting traceability QR code supervision requirements was identified.

3. Key Monitoring Enterprise Situation

According to the “2025 Veterinary Drug Quality Supervision and Sampling Plan” key monitoring enterprise determination principles, the following enterprises are designated as key monitoring enterprises:

(1) Shandong Hengguan Biotechnology Co., Ltd. The content of the active ingredient in the injectable Lincomycin hydrochloride was 0 during sampling, verified to be produced by the claimed veterinary drug manufacturer.

(2) Shandong Jinyang Biopharmaceutical Co., Ltd. During provincial supervision and sampling, illegal additive ketoprofen was detected in enrofloxacin injection.

4. Relevant Work Requirements

For counterfeit and inferior veterinary drugs found during sampling, local authorities should promptly follow the requirements of the “Veterinary Drug Quality Supervision and Inspection Management Measures” and the “2025 Veterinary Drug Quality Supervision and Sampling Plan,” carry out traceability and investigation, and strictly investigate illegal and irregular behaviors according to law. After case handling is completed, provincial veterinary and animal husbandry departments should promptly report relevant law enforcement and case handling information to our Department of Animal Husbandry and Veterinary Medicine and the Department of Regulations, and organize relevant units to disclose case information according to law; for cases that meet the conditions for revoking veterinary drug approval numbers, timely recommendations for revocation should be submitted to our Department of Animal Husbandry and Veterinary Medicine.

Contact person and phone:

Department of Animal Husbandry and Veterinary Medicine, Ministry of Agriculture and Rural Affairs, Wang Zidong 010–59193267

1. Summary table of unqualified veterinary biological products at the department level in Q4 2025

2. Summary table of unqualified provincial supervision and sampling non-biological veterinary drug products in Q4 2025

3. Summary table of department-level follow-up unqualified non-biological veterinary drug products in Q4 2025

4. Summary table of counterfeit veterinary drugs and products not meeting traceability QR code supervision requirements

General Office of the Ministry of Agriculture and Rural Affairs

March 16, 2026